Cyclo Therapeutics, Inc. (CYTH)
NASDAQ: CYTH · Real-Time Price · USD
0.928
-0.262 (-22.02%)
At close: Feb 10, 2025, 7:59 PM
0.902
-0.026 (-2.80%)
Pre-market: Feb 11, 2025, 8:12 AM EST
Cyclo Therapeutics Market Cap
Cyclo Therapeutics has a market cap or net worth of $26.70 million as of February 11, 2025. Its market cap has decreased by -35.52% in one year.
Market Cap
26.70M
Enterprise Value
37.97M
1-Year Change
-35.52%
Ranking
Category
Stock Price
$0.93
Market Cap Chart
Since December 9, 2020, Cyclo Therapeutics's market cap has increased from $16.80M to $26.70M, an increase of 58.91%. That is a compound annual growth rate of 11.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 7, 2025 | 34.20M | 101.18% |
| Dec 31, 2024 | 17.00M | -52.91% |
| Dec 29, 2023 | 36.10M | 200.83% |
| Dec 30, 2022 | 12.00M | -50.21% |
| Dec 31, 2021 | 24.10M | 38.51% |
| Dec 31, 2020 | 17.40M | 3.57% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 782.37B |
| UnitedHealth Group | 490.85B |
| Novo Nordisk | 377.75B |
| Johnson & Johnson | 371.35B |
| AbbVie | 336.36B |
| Abbott Laboratories | 227.75B |
| AstraZeneca | 225.08B |
| Merck & Co. | 218.56B |